{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:10:59Z","timestamp":1778904659802,"version":"3.51.4"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.2169\/internalmedicine.5919-25","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:08:35Z","timestamp":1760566115000},"page":"1392-1396","source":"Crossref","is-referenced-by-count":2,"title":["Central Retinal Artery Occlusion Induced by Dupilumab: A Unique Manifestation of Eosinophilic Granulomatosis with Polyangiitis"],"prefix":"10.2169","volume":"65","author":[{"given":"Takeshi","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieko","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Suga","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kajiwara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fujiki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kusakabe","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Saiseikai-Noe Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beck LA, Tha\u00e7i D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371: 130-139, 2014.","DOI":"10.1056\/NEJMoa1314768"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Castro M, Corren J, Pavord ID, et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378: 2486-2496, 2018.","DOI":"10.1056\/NEJMoa1804092"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394: 1638-1650, 2019.","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kushima Y, Shimizu Y, Hoshi H, et al. Changes in peripheral blood eosinophil counts and risk of eosinophilic granulomatosis with polyangiitis onset after initiation of dupilumab administration in adult patients with asthma. J Clin Med 12: 2023.","DOI":"10.3390\/jcm12175721"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Li SH, Nehme KF, Moshkovich A, et al. Eosinophilia and adverse effects of dupilumab for respiratory indications: a real-world setting. J Allergy Clin Immunol Pract 13: 121-131, 2025.","DOI":"10.1016\/j.jaip.2024.09.013"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Suzaki I, Tanaka A, Yanai R, et al. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report. BMC Pulm Med 23: 130, 2023.","DOI":"10.1186\/s12890-023-02415-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamazaki K, Nomizo T, Hatanaka K, Hayama N, Oguma T, Asano K. Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab. J Allergy Clin Immunol Glob 1: 180-182, 2022.","DOI":"10.1016\/j.jacig.2022.03.006"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int 68: 430-436, 2019.","DOI":"10.1016\/j.alit.2019.06.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Akella SS, Schlachter DM, Black EH, Barmettler A. Ophthalmic eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a systematic review of the literature. Ophthalmic Plast Reconstr Surg 35: 7-16, 2019.","DOI":"10.1097\/IOP.0000000000001202"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Andr\u00e9 R, Cottin V, Saraux JL, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev 16: 963-969, 2017.","DOI":"10.1016\/j.autrev.2017.07.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Caminati M, Fassio A, Alberici F, et al. Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: report from the European EGPA study group. Allergy 79: 516-519, 2024.","DOI":"10.1111\/all.15934"},{"key":"12","unstructured":"12. The Japanese Ministry of Health. Labour and Welfare criteria for eosinophilic granulomatosis with polyangiitis. [Internet]. [cited 2025 Aug 11]. Available from: https:\/\/www.nanbyou.or.jp\/entry\/3878"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68: 1827-1832, 2009.","DOI":"10.1136\/ard.2008.101279"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis. Ann Rheum Dis 81: 309-314, 2022.","DOI":"10.1002\/art.41982"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33: 1094-1100, 1990.","DOI":"10.1002\/art.1780330806"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hauser T, Mahr A, Metzler C, et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 63: 677-682, 2008.","DOI":"10.1136\/thx.2007.087825"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chapuis E, Bousquet E, Viallard JF, et al. Ophthalmic vascular manifestations in eosinophil-associated diseases: a comprehensive analysis of 57 patients from the CEREO and EESG networks and a literature review. Front Immunol 15: 1379611, 2024.","DOI":"10.3389\/fimmu.2024.1379611"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wechsler ME, Klion AD, Paggiaro P, et al. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract 10: 2695-2709, 2022.","DOI":"10.1016\/j.jaip.2022.05.019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Watanabe R, Hashimoto M. Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations. J Clin Med 12: 2023.","DOI":"10.3390\/jcm12185996"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Eger K, Pet L, Weersink EJM, Bel EH. Complications of switching from anti-IL-5 or anti-IL-5R to dupilumab in corticosteroid-dependent severe asthma. J Allergy Clin Immunol Pract 9: 2913-2915, 2021.","DOI":"10.1016\/j.jaip.2021.02.042"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. von Deimling M, Koehler TC, Frye BC, Maerker-Hermann E, Venhoff N. Two cases with new onset of ANCA-positive eosinophilic granulomatosis with polyangiitis under treatment with dupilumab: coincidence or causality? Ann Rheum Dis 82: 580-582, 2023.","DOI":"10.1136\/ard-2022-223596"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Matucci A, Micheletto C, Vultaggio A. Severe asthma and biologics: managing complex patients. J Investig Allergol Clin Immunol 33: 168-178, 2023.","DOI":"10.18176\/jiaci.0856"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nishiyama H, Tajiri T, Yamabe T, et al. Eosinophilic granulomatosis with polyangiitis presenting with central retinal artery occlusion during treatment with anti-interleukin-5 receptor monoclonal antibody. Intern Med 60: 3631-3634, 2021.","DOI":"10.2169\/internalmedicine.7027-21"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hayreh SS, Zimmerman MB, Kimura A, Sanon A. Central retinal artery occlusion. Retinal survival time. Exp Eye Res 78: 723-736, 2004.","DOI":"10.1016\/S0014-4835(03)00214-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_5919-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:48Z","timestamp":1778902008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/10\/65_5919-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5919-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"5919-25"}}